Clinical Trials Directory

Trials / Terminated

TerminatedNCT02877732

EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years – 25 Years
Healthy volunteers
Accepted

Summary

This is a prospective multi-center cohort feasibility and exploratory study.

Detailed description

Investigators propose to prospectively study a cohort of 18-25-year-old athletes to establish the reliability of EYE-SYNC data and the utility of the EYE-SYNC eye-tracking device as a sideline concussion assessment tool. The clinical research study will be conducted to 1) determine if eye-tracking, assessed on the sideline by EYE-SYNC eye-tracking device, is a potential marker of injury that can be used in conjunction with other sideline evaluations to inform decisions regarding removal of athletes from play and 2) to use the EYE-SYNC goggle data as a post- injury recovery monitor.

Conditions

Interventions

TypeNameDescription
DEVICEEYE-SYNC eye-trackingThe EYE-SYNC® portable eye-tracking system. The eye tracker is a handheld isolated display environment with embedded eye tracking sensors. The eye tracker is connected to a high-performance Windows tablet though a customized docking station. Included accessories with EYE-SYNC are a U.S. tablet power supply adapter and disposable sanitary masks. Participants are asked to follow a dot with their eyes, as the dot moves on the screen of the EYE-SYNC device.
OTHERSCAT-3 subtestsFollowing subtests of SCAT-3 will be administered to the participant: Symptom, Balance, Orientation and Immediate memory
OTHERDEMParticipant will be asked to read list of numbers out loud from a card
OTHERSimple Reaction Time subtest of ANAM-SRTParticipants will perform Simple Reaction Time sub-test of ANAM-SRT test. They will be asked to click the mouse button every time they see an asterisk on the screen. Participants will perform ANAM-SRT 1 and ANAM-SRT 2 in this study.
OTHERLevel of AlertnesssParticipants will answer questions. This assessment is to assess their alertness level.

Timeline

Start date
2016-07-01
Primary completion
2017-04-01
Completion
2017-04-01
First posted
2016-08-24
Last updated
2018-05-30
Results posted
2018-04-30

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02877732. Inclusion in this directory is not an endorsement.